Disease-Free SurvivalRetrospective StudiesSurvival RatePrognosisNeoplasm StagingTreatment OutcomeSurvival AnalysisNeoplasm Recurrence, LocalCombined Modality TherapyBreast NeoplasmsKaplan-Meier EstimateFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantTumor Markers, BiologicalLymphatic MetastasisRadiotherapy, AdjuvantProportional Hazards ModelsImmunohistochemistryCell SurvivalRadiotherapy DosageTime FactorsFluorouracilCarcinoma, Squamous CellNeoplasm InvasivenessMultivariate AnalysisColorectal NeoplasmsCyclophosphamideRecurrenceCarcinoma, Ductal, BreastCarcinomaLiver NeoplasmsAdenocarcinomaImmunoenzyme TechniquesReceptors, EstrogenProspective StudiesPredictive Value of TestsReceptor, erbB-2Risk FactorsGene Expression Regulation, NeoplasticSurvivalNeoplasm MetastasisCisplatinLung NeoplasmsCohort StudiesAntineoplastic AgentsGraft SurvivalNeoplasm GradingVincristineDisease ProgressionBone NeoplasmsNeoadjuvant TherapyRemission InductionDoxorubicinAge FactorsDrug Administration ScheduleEtoposideChemoradiotherapyCarcinoma, Non-Small-Cell LungSalvage TherapyOvarian NeoplasmsMethotrexateReceptors, ProgesteroneRadiotherapySarcomaHead and Neck NeoplasmsRisk AssessmentPrednisoneLymphoma, Non-HodgkinLymph Node ExcisionBrachytherapyActuarial AnalysisFree RadicalsCarboplatinHodgkin DiseaseCarcinoma, HepatocellularLymph NodesHematopoietic Stem Cell TransplantationNeoplasms, Germ Cell and EmbryonalPancreatic NeoplasmsTransplantation, AutologousTransplantation, HomologousNeoplasm ProteinsBrain NeoplasmsOsteosarcomaNeoplasm, ResidualStomach NeoplasmsPaclitaxelRectal NeoplasmsAntineoplastic Agents, HormonalPostoperative ComplicationsTamoxifenAntibodies, MonoclonalUterine Cervical NeoplasmsDose FractionationMediastinal NeoplasmsTomography, X-Ray ComputedMelanomaKidney NeoplasmsHepatectomy